Yield Theory

Julie Johnson · JNJ

Julie Johnson's JNJ trades

Every Johnson & Johnson transaction Julie Johnson reported to the House Clerk in 2025 and 2026, from the original periodic transaction reports.
Transactions
4
Buys / sells
0 / 4
Disclosed range
$4K – $60K
Last filed
2026-01-15

JNJ transactions reported by Julie Johnson

4 of 4 rows
TypeOwner
Johnson & Johnson Common Stock
JNJ
SaleJoint$1,001 - $15,0002026-01-15
#20033789
Johnson & Johnson Common Stock
JNJ
SaleJoint$1,001 - $15,0002025-12-11
#20033611
Johnson & Johnson Common Stock
JNJ
SaleJoint$1,001 - $15,0002025-09-11
#20032066
Johnson & Johnson Common Stock
JNJ
SaleJoint$1,001 - $15,0002025-05-14
#20030296

A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.

The tracker is free

A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.

Get this month’s call for $15

Julie Johnson and JNJ — questions

Did Julie Johnson buy or sell JNJ?

House Clerk filings for 2025 and 2026 show 0 purchases and 4 sales of Johnson & Johnson (JNJ) reported by Julie Johnson, between 2025-04-01 and 2025-12-18. Reported owner: Joint.

How much JNJ did Julie Johnson trade?

Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $4K – $60K across 4 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.

When was the last JNJ filing by Julie Johnson?

The most recent periodic transaction report containing a JNJ row was filed on 2026-01-15. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.

Yield Theory is not affiliated with any elected official or with Johnson & Johnson. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.

Don’t copy the filing. Read the thesis.

Julie Johnson JNJ disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included